CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein
- 14 November 1997
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 73 (4) , 531-536
- https://doi.org/10.1002/(sici)1097-0215(19971114)73:4<531::aid-ijc13>3.0.co;2-c
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Temperature-Sensitive Mutants of p16CDKN2 Associated with Familial MelanomaMolecular and Cellular Biology, 1996
- Familial Melanoma and Pancreatic CancerNew England Journal of Medicine, 1996
- Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4MutationsNew England Journal of Medicine, 1995
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- Germline p16 mutations in familial melanomaNature Genetics, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Assignment of a Locus for Familial Melanoma, MLM, to Chromosome 9p13-p22Science, 1992
- Systemic cancer and the FAMMM syndromeBritish Journal of Cancer, 1990
- Tumour spectrum in the FAMMM syndromeBritish Journal of Cancer, 1981
- Origin of Familial Malignant Melanomas From Heritable Melanocytic LesionsArchives of Dermatology, 1978